Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 15,298 | 14,177 | 4,011 | 6,644 | 9,803 |
| Cost of Goods | 12,401 | 4,292 | 1,052 | 336 | 260 |
| Gross Profit | 2,897 | 9,885 | 2,959 | 6,308 | 9,543 |
| Operating Expenses | 90,479 | 79,321 | 106,706 | 91,944 | 95,654 |
| Operating Income | -87,181 | -69,144 | -103,695 | -85,300 | -85,851 |
| Interest Expense | 6,098 | 5,957 | 4,104 | 2,581 | 3,360 |
| Other Income | 4,393 | 3,924 | 1,828 | 3,371 | -2,290 |
| Pre-tax Income | -88,886 | -71,177 | -105,971 | -84,510 | -91,501 |
| Net Income Continuous | -88,886 | -71,177 | -105,971 | -84,510 | -91,501 |
| Minority Interests | -338 | 126 | 223 | -332 | 280 |
| Net Income | $-88,548 | $-71,303 | $-106,194 | $-84,178 | $-91,781 |
| EPS Basic Total Ops | -1.34 | -1.08 | -1.61 | -1.28 | -1.44 |
| EPS Basic Continuous Ops | -1.34 | -1.08 | -1.61 | -1.29 | -1.44 |
| EPS Diluted Total Ops | -1.34 | -1.08 | -1.61 | -1.28 | -1.44 |
| EPS Diluted Continuous Ops | -1.34 | -1.08 | -1.61 | -1.29 | -1.44 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -1.04 | N/A | N/A | N/A |
| EBITDA(a) | $-86,727 | $-68,842 | $-103,478 | $-85,035 | $-85,560 |